Ziprasidone-d8

• Description :

  Ziprasidone-d88 is deuterium labeled Ziprasidone, which is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.

• Product Name Alternative :

  CP-88059 D8

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  5-HT Receptor; Dopamine Receptor; Isotope-Labeled Compounds

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling; Others

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Purity :

  98.0

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1CC2=CC(CCN(C([2H])([2H])C3([2H])[2H])C([2H])([2H])C([2H])([2H])N3C4=NSC5=C4C=CC=C5)=C(Cl)C=C2N1

• Molecular Formula :

  C21H13D8ClN4OS

• Molecular Weight :

  420.98

• Precautions :

  H302, H315, H319, H335

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• CAS Number :

  [1126745-58-1]